ブデソニドの世界市場レポート2020

• 英文タイトル：Global Budesonide Sales Market Report 2020

• レポートコード：20QY06-03265 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、ブデソニドのグローバル市場について種類別（注射用懸濁液、エアロゾル、吸入パウダー、錠剤及びカプセル）、用途別（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ブデソニド市場の概要 ・世界の主要地域別ブデソニド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のブデソニド市場規模2015-2026：種類別（注射用懸濁液、エアロゾル、吸入パウダー、錠剤及びカプセル） ・世界のブデソニド市場規模2015-2026：用途別（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他） ・ブデソニドの北米市場規模2015-2020 ・ブデソニドのヨーロッパ市場規模2015-2020 ・ブデソニドの中国市場規模2015-2020 ・ブデソニドの日本市場規模2015-2020 ・ブデソニドの東南アジア市場規模2015-2020 ・ブデソニドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AstraZeneca、、Teva、、Mylan、、Sandoz、、Cosmo Pharmaceuticals、、Salix、、Chiesi Farmaceutici、、Orion Corporation、、Cipla、、Synmosa Biopharma、、Lunan Better Pharma、、Shanghai Sine Promod、） ・ブデソニドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ブデソニドの市場動向・機会・課題 ・調査の結論

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn’s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

The industry’s leading manufacturers are AstraZeneca and Teva, with 52.93% and 16.78% of revenue, respectively. By region, North America has the highest share of income, at around 36.5% in 2019.

Market Analysis and Insights: Global Budesonide Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Budesonide market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Budesonide industry.

Based on our recent survey, we have several different scenarios about the Budesonide YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 7548.9 million in 2019. The market size of Budesonide will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Budesonide Scope and Market Size

The global Budesonide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Budesonide market is segmented into

Injectable Suspension

Aerosols

Inhalation Powder

Tablet and Capsule

Segment by Application, the Budesonide market is segmented into

Respiratory Disease Treatment

Nose Disease Treatment

Inflammatory Bowel Disease Treatment

Others

The Budesonide market is analysed and market size information is provided by regions (countries). Segment by Application, the Budesonide market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Budesonide Market Share Analysis

Budesonide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Budesonide business, the date to enter into the Budesonide market, Budesonide product introduction, recent developments, etc.

The major vendors covered:

AstraZeneca

Teva

Mylan

Sandoz

Cosmo Pharmaceuticals

Salix

Chiesi Farmaceutici

Orion Corporation

Cipla

Synmosa Biopharma

Lunan Better Pharma

Shanghai Sine Promod

レポート目次

---

1 Budesonide Market Overview

1.1 Budesonide Product Scope

1.2 Budesonide Segment by Type

1.2.1 Global Budesonide Sales by Type (2020-2026)

1.2.2 Injectable Suspension

1.2.3 Aerosols

1.2.4 Inhalation Powder

1.2.5 Tablet and Capsule

1.3 Budesonide Segment by Application

1.3.1 Global Budesonide Sales Comparison by Application (2020-2026)

1.3.2 Respiratory Disease Treatment

1.3.3 Nose Disease Treatment

1.3.4 Inflammatory Bowel Disease Treatment

1.3.5 Others

1.4 Budesonide Market Estimates and Forecasts (2015-2026)

1.4.1 Global Budesonide Sales Growth Rate (2015-2026)

1.4.2 Global Budesonide Revenue and Growth Rate (2015-2026)

1.4.3 Global Budesonide Price Trends (2015-2026)

1.5 Coronavirus Disease 2019 (Covid-19): Budesonide Industry Impact

1.5.1 How the Covid-19 is Affecting the Budesonide Industry

1.5.1.1 Budesonide Business Impact Assessment – Covid-19

1.5.1.2 Supply Chain Challenges

1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.5.2 Market Trends and Budesonide Potential Opportunities in the COVID-19 Landscape

1.5.3 Measures / Proposal against Covid-19

1.5.3.1 Government Measures to Combat Covid-19 Impact

1.5.3.2 Proposal for Budesonide Players to Combat Covid-19 Impact

2 Budesonide Estimate and Forecast by Region

2.1 Global Budesonide Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Budesonide Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Budesonide Sales Market Share by Region (2015-2020)

2.2.2 Global Budesonide Revenue Market Share by Region (2015-2020)

2.3 Global Budesonide Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Budesonide Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Budesonide Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Budesonide Estimates and Projections (2015-2026)

2.4.2 Europe Budesonide Estimates and Projections (2015-2026)

2.4.3 China Budesonide Estimates and Projections (2015-2026)

2.4.4 Japan Budesonide Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Budesonide Estimates and Projections (2015-2026)

2.4.6 India Budesonide Estimates and Projections (2015-2026)

3 Global Budesonide Competition Landscape by Players

3.1 Global Top Budesonide Players by Sales (2015-2020)

3.2 Global Top Budesonide Players by Revenue (2015-2020)

3.3 Global Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2019)

3.4 Global Budesonide Average Price by Company (2015-2020)

3.5 Manufacturers Budesonide Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Budesonide Players (Opinion Leaders)

4 Global Budesonide Market Size by Type

4.1 Global Budesonide Historic Market Review by Type (2015-2020)

4.1.1 Global Budesonide Sales Market Share by Type (2015-2020)

4.1.2 Global Budesonide Revenue Market Share by Type (2015-2020)

4.1.3 Global Budesonide Price by Type (2014-2020)

4.2 Global Budesonide Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Budesonide Sales Forecast by Type (2021-2026)

4.2.2 Global Budesonide Revenue Forecast by Type (2021-2026)

4.2.3 Global Budesonide Price Forecast by Type (2021-2026)

5 Global Budesonide Market Size by Application

5.1 Global Budesonide Historic Market Review by Application (2015-2020)

5.1.1 Global Budesonide Sales Market Share by Application (2015-2020)

5.1.2 Global Budesonide Revenue Market Share by Application (2015-2020)

5.1.3 Global Budesonide Price by Application (2015-2020)

5.2 Global Budesonide Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Budesonide Sales Forecast by Application (2021-2026)

5.2.2 Global Budesonide Revenue Forecast by Application (2021-2026)

5.2.3 Global Budesonide Price Forecast by Application (2021-2026)

3 North America Budesonide Market Facts & Figures

3.2 North America Budesonide Sales Market Share by Company (2015-2020)

3.3 North America Budesonide Sales Market Share by Type (2015-2020)

3.4 North America Budesonide Sales Market Share by Application (2015-2020)

4 Europe Budesonide Market Facts & Figures

4.2 Europe Budesonide Sales Market Share by Company (2015-2020)

4.3 Europe Budesonide Sales Market Share by Type (2015-2020)

4.4 Europe Budesonide Sales Market Share by Application (2015-2020)

5 China Budesonide Market Facts & Figures

5.2 China Budesonide Sales Market Share by Company (2015-2020)

5.3 China Budesonide Sales Market Share by Type (2015-2020)

5.4 China Budesonide Sales Market Share by Application (2015-2020)

6 Japan Budesonide Market Facts & Figures

6.2 Japan Budesonide Sales Market Share by Company (2015-2020)

6.3 Japan Budesonide Sales Market Share by Type (2015-2020)

6.4 Japan Budesonide Sales Market Share by Application (2015-2020)

7 Southeast Asia Budesonide Market Facts & Figures

7.2 Southeast Asia Budesonide Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Budesonide Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Budesonide Sales Market Share by Application (2015-2020)

8 India Budesonide Market Facts & Figures

8.2 India Budesonide Sales Market Share by Company (2015-2020)

8.3 India Budesonide Sales Market Share by Type (2015-2020)

8.4 India Budesonide Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Budesonide Business

12.1 AstraZeneca

12.1.1 AstraZeneca Budesonide Corporation Information

12.1.2 AstraZeneca Budesonide Business Overview and Total Revenue

12.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.1.4 AstraZeneca Budesonide Products Offered

12.1.5 AstraZeneca Recent Development

12.2 Teva

12.2.1 Teva Budesonide Corporation Information

12.2.2 Teva Budesonide Business Overview and Total Revenue

12.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Teva Budesonide Products Offered

12.2.5 Teva Recent Development

12.3 Mylan

12.3.1 Mylan Budesonide Corporation Information

12.3.2 Mylan Budesonide Business Overview and Total Revenue

12.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Mylan Budesonide Products Offered

12.3.5 Mylan Recent Development

12.4 Sandoz

12.4.1 Sandoz Budesonide Corporation Information

12.4.2 Sandoz Budesonide Business Overview and Total Revenue

12.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Sandoz Budesonide Products Offered

12.4.5 Sandoz Recent Development

12.5 Cosmo Pharmaceuticals

12.5.1 Cosmo Pharmaceuticals Budesonide Corporation Information

12.5.2 Cosmo Pharmaceuticals Budesonide Business Overview and Total Revenue

12.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Cosmo Pharmaceuticals Budesonide Products Offered

12.5.5 Cosmo Pharmaceuticals Recent Development

12.6 Salix

12.6.1 Salix Budesonide Corporation Information

12.6.2 Salix Budesonide Business Overview and Total Revenue

12.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Salix Budesonide Products Offered

12.6.5 Salix Recent Development

12.7 Chiesi Farmaceutici

12.7.1 Chiesi Farmaceutici Budesonide Corporation Information

12.7.2 Chiesi Farmaceutici Budesonide Business Overview and Total Revenue

12.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Chiesi Farmaceutici Budesonide Products Offered

12.7.5 Chiesi Farmaceutici Recent Development

12.8 Orion Corporation

12.8.1 Orion Corporation Budesonide Corporation Information

12.8.2 Orion Corporation Budesonide Business Overview and Total Revenue

12.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Orion Corporation Budesonide Products Offered

12.8.5 Orion Corporation Recent Development

12.9 Cipla

12.9.1 Cipla Budesonide Corporation Information

12.9.2 Cipla Budesonide Business Overview and Total Revenue

12.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.9.4 Cipla Budesonide Products Offered

12.9.5 Cipla Recent Development

12.10 Synmosa Biopharma

12.10.1 Synmosa Biopharma Budesonide Corporation Information

12.10.2 Synmosa Biopharma Budesonide Business Overview and Total Revenue

12.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.10.4 Synmosa Biopharma Budesonide Products Offered

12.10.5 Synmosa Biopharma Recent Development

12.11 Lunan Better Pharma

12.11.1 Lunan Better Pharma Budesonide Corporation Information

12.11.2 Lunan Better Pharma Budesonide Business Overview and Total Revenue

12.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.11.4 Lunan Better Pharma Budesonide Products Offered

12.11.5 Lunan Better Pharma Recent Development

12.12 Shanghai Sine Promod

12.12.1 Shanghai Sine Promod Budesonide Corporation Information

12.12.2 Shanghai Sine Promod Budesonide Business Overview and Total Revenue

12.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2015-2020)

12.12.4 Shanghai Sine Promod Budesonide Products Offered

12.12.5 Shanghai Sine Promod Recent Development

13 Budesonide Manufacturing Cost Analysis

13.1 Budesonide Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Budesonide

13.4 Budesonide Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Budesonide Distributors List

14.3 Budesonide Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

Table 1. Global Budesonide Sales (M Units) Growth Rate by Type (2020-2026)

Table 2. Global Budesonide Sales (M Units) Comparison by Application (2020-2026)

Table 3. COVID-19 Impact Global Market: (Four Budesonide Market Size Forecast Scenarios)

Table 4. Opportunities and Trends for Budesonide Players in the COVID-19 Landscape

Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 6. Key Regions/Countries Measures against Covid-19 Impact

Table 7. Proposal for Budesonide Players to Combat Covid-19 Impact

Table 8. Global Market Budesonide Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 9. Global Budesonide Sales (M Units) by Region (2015-2020)

Table 10. Global Budesonide Sales Market Share by Region (2015-2020)

Table 11. Global Budesonide Revenue (US$ Million) Market Share by Region (2015-2020))

Table 12. Global Budesonide Revenue Share by Region (2015-2020)

Table 13. Global Budesonide Sales (M Units) Forecast by Region (2021-2026)

Table 14. Global Budesonide Sales Market Share Forecast by Region (2021-2026)

Table 15. Global Budesonide Revenue (US$ Million) Forecast by Region (2021-2026)

Table 16. Global Budesonide Revenue Share Forecast by Region (2021-2026)

Table 17. Global Budesonide (M Units) of Key Companies (2015-2020)

Table 18. Global Budesonide Sales Share by Company (2015-2020)

Table 19. Global Budesonide Revenue (US$ Million) by Company (2015-2020)

Table 20. Global Budesonide Revenue Share by Company (2015-2020)

Table 21. Global Budesonide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Budesonide as of 2019)

Table 22. Global Budesonide Average Price (US$/K Units) of Key Company (2015-2020)

Table 23. Manufacturers Budesonide Manufacturing Sites and Area Served

Table 24. Manufacturers Budesonide Product Type

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Main Points Interviewed from Key Budesonide Players

Table 27. Global Budesonide Sales (M Units) by Type (2015-2020)

Table 28. Global Budesonide Sales Share by Type (2015-2020)

Table 29. Global Budesonide Revenue (US$ Million) Market Share by Type (2015-2020)

Table 30. Global Budesonide Price (M Units) by Type (2015-2020)

Table 31. Global Budesonide Sales Share by Type (2021-2026)

Table 32. Global Budesonide Revenue (US$ Million) Market Share by Type (2021-2026)

Table 33. Global Budesonide Revenue Share by Type (2021-2026)

Table 34. Global Budesonide Price (M Units) by Type (2021-2026)

Table 35. Global Budesonide Sales (M Units) by Application (2015-2020)

Table 36. Global Budesonide Sales Share by Application (2015-2020)

Table 37. Global Budesonide Revenue (US$ Million) Market Share by Application (2015-2020)

Table 38. Global Budesonide Price (M Units) by Application (2015-2020)

Table 39. Global Budesonide Sales (M Units) by Application (2021-2026)

Table 40. Global Budesonide Sales Share by Application (2021-2026)

Table 41. Global Budesonide Revenue (US$ Million) Market Share by Application (2021-2026)

Table 42. Global Budesonide Revenue Share by Application (2021-2026)

Table 43. Global Budesonide Price (M Units) by Application (2021-2026)

Table 44. United States Budesonide Sales (M Units) by Company (2015-2020)

Table 45. United States Budesonide Sales Market Share by Company (2015-2020)

Table 46. United States Budesonide Sales (M Units) by Type (2015-2020)

Table 47. United States Budesonide Sales Market Share by Type (2015-2020)

Table 48. United States Budesonide Sales (M Units) by Application (2015-2020)

Table 49. United States Budesonide Sales Market Share by Application (2015-2020)

Table 50. Europe Budesonide Sales (M Units) by Company (2015-2020)

Table 51. Europe Budesonide Sales Market Share by Company (2015-2020)

Table 52. Europe Budesonide Sales (M Units) by Type (2015-2020)

Table 53. Europe Budesonide Sales Market Share by Type (2015-2020)

Table 54. Europe Budesonide Sales (M Units) by Application (2015-2020)

Table 55. Europe Budesonide Sales Market Share by Type (2015-2020)

Table 56. China Budesonide Sales (M Units) by Company (2015-2020)

Table 57. China Budesonide Sales Market Share by Company (2015-2020)

Table 58. China Budesonide Sales (M Units) by Type (2015-2020)

Table 59. China Budesonide Sales Market Share by Type (2015-2020)

Table 60. China Budesonide Sales (M Units) by Application (2015-2020)

Table 61. China Budesonide Sales Market Share by Application (2015-2020)

Table 62. Japan Budesonide Sales (M Units) by Company (2015-2020)

Table 63. Japan Budesonide Sales Market Share by Company (2015-2020)

Table 64. Japan Budesonide Sales (M Units) by Type (2015-2020)

Table 65. Japan Budesonide Sales Market Share by Type (2015-2020)

Table 66. Japan Budesonide Sales (M Units) by Application (2015-2020)

Table 67. Japan Budesonide Sales Market Share by Application (2015-2020)

Table 68. Southeast Asia Budesonide Sales (M Units) by Company (2015-2020)

Table 69. Southeast Asia Budesonide Sales Market Share by Company (2015-2020)

Table 70. Southeast Asia Budesonide Sales (M Units) by Type (2015-2020)

Table 71. Southeast Asia Budesonide Sales Market Share by Type (2015-2020)

Table 72. Southeast Asia Budesonide Sales (M Units) by Type (2015-2020)

Table 73. Southeast Asia Budesonide Sales Market Share by Application (2015-2020)

Table 74. India Budesonide Sales (M Units) by Company (2015-2020)

Table 75. India Budesonide Sales Market Share by Company (2015-2020)

Table 76. India Budesonide Sales (M Units) by Type (2015-2020)

Table 77. India Budesonide Sales Market Share by Type (2015-2020)

Table 78. India Budesonide Sales (M Units) by Application (2015-2020)

Table 79. India Budesonide Sales Market Share by Application (2015-2020)

Table 80. AstraZeneca Corporation Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 83. AstraZeneca Budesonide Product

Table 84. AstraZeneca Recent Development

Table 85. Teva Corporation Information

Table 86. Teva Description and Business Overview

Table 87. Teva Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 88. Teva Budesonide Product

Table 89. Teva Recent Development

Table 90. Mylan Corporation Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 93. Mylan Budesonide Product

Table 94. Mylan Recent Development

Table 95. Sandoz Corporation Information

Table 96. Sandoz Description and Business Overview

Table 97. Sandoz Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 98. Sandoz Budesonide Product

Table 99. Sandoz Recent Development

Table 100. Cosmo Pharmaceuticals Corporation Information

Table 101. Cosmo Pharmaceuticals Description and Business Overview

Table 102. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 103. Cosmo Pharmaceuticals Budesonide Product

Table 104. Cosmo Pharmaceuticals Recent Development

Table 105. Salix Corporation Information

Table 106. Salix Description and Business Overview

Table 107. Salix Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 108. Salix Budesonide Product

Table 109. Salix Recent Development

Table 110. Chiesi Farmaceutici Corporation Information

Table 111. Chiesi Farmaceutici Description and Business Overview

Table 112. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 113. Chiesi Farmaceutici Budesonide Product

Table 114. Chiesi Farmaceutici Recent Development

Table 115. Orion Corporation Corporation Information

Table 116. Orion Corporation Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 117. Orion Corporation Description and Business Overview

Table 118. Orion Corporation Budesonide Product

Table 119. Orion Corporation Recent Development

Table 120. Cipla Corporation Information

Table 121. Cipla Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 122. Cipla Description and Business Overview

Table 123. Cipla Budesonide Product

Table 124. Cipla Recent Development

Table 125. Synmosa Biopharma Corporation Information

Table 126. Synmosa Biopharma Description and Business Overview

Table 127. Synmosa Biopharma Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 128. Synmosa Biopharma Budesonide Product

Table 129. Synmosa Biopharma Recent Development

Table 130. Lunan Better Pharma Corporation Information

Table 131. Lunan Better Pharma Description and Business Overview

Table 132. Lunan Better Pharma Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table 133. Lunan Better Pharma Budesonide Product

Table 134. Lunan Better Pharma Recent Development

Table . Shanghai Sine Promod Corporation Information

Table . Shanghai Sine Promod Description and Business Overview

Table . Shanghai Sine Promod Budesonide Sales (M Units), Revenue (Million USD), Price (US$/K Units) and Gross Margin (2015-2020)

Table . Shanghai Sine Promod Budesonide Product

Table . Shanghai Sine Promod Recent Development

Table 140. Production Base and Market Concentration Rate of Raw Material

Table 141. Key Suppliers of Raw Materials

Table 142. Budesonide Distributors List

Table 143. Budesonide Customers List

Table 144. Market Key Trends

Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 146. Key Challenges

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Budesonide Product Picture

Figure 2. Global Budesonide Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Budesonide Market Share by Application in 2020 & 2026

Figure 6. Respiratory Disease Treatment Examples

Figure 7. Nose Disease Treatment Examples

Figure 8. Inflammatory Bowel Disease Treatment Examples

Figure 9. Others Examples

Figure 10. Global Budesonide Sales (M Units) Growth Rate (2015-2026)

Figure 11. Global Budesonide Revenue (US$ Million) Growth Rate (2015-2026)

Figure 12. Global Budesonide Price Trends Growth Rate (2015-2026) (US$/K Units)

Figure 13. Global Budesonide Revenue Market Share by Region: 2015 VS 2020

Figure 14. Global Budesonide Revenue Market Share by Region: 2021 VS 2026

Figure 15. United States Budesonide Revenue (Million USD) Growth Rate (2015-2026)

Figure 16. United States Budesonide Sales (M Units) Growth Rate (2015-2026)

Figure 17. Europe Budesonide Revenue (Million USD) Growth Rate (2015-2026)

Figure 18. Europe Budesonide Sales (Million USD) Growth Rate (2015-2026)

Figure 19. China Budesonide Revenue (Million USD) Growth Rate (2015-2026)

Figure 20. China Budesonide Sales (Million USD) and Growth Rate (2015-2026)

Figure 21. Japan Budesonide Revenue (Million USD) Growth Rate (2015-2026)

Figure 22. Japan Budesonide Sales (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia Budesonide Revenue (Million USD) Growth Rate (2015-2026)

Figure 24. Southeast Asia Budesonide Sales (Million USD) Growth Rate (2015-2026)

Figure 25. India Budesonide Revenue (Million USD) Growth Rate (2015-2026)

Figure 26. India Budesonide Sales (Million USD) Growth Rate (2015-2026)

Figure 27. Global 5 Largest Budesonide Players Market Share by Revenue in Budesonide 2015 & 2019

Figure 28. Budesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 29. Global Budesonide Revenue Share by Type (2015-2020)

Figure 30. Global Budesonide Revenue Growth Rate by Type in 2015 & 2019

Figure 31. Global Budesonide Revenue Share by Application (2015-2020)

Figure 32. Global Budesonide Revenue Growth Rate by Application in 2015 & 2019

Figure 33. United States Budesonide Sales Market Share by Type in 2019

Figure 34. United States Budesonide Sales Market Share by Type in 2019

Figure 35. Europe Budesonide Sales Market Share by Company in 2019

Figure 36. Europe Budesonide Sales Market Share by Type in 2019

Figure 37. Europe Budesonide Sales Market Share by Application in 2019

Figure 38. China Budesonide Sales Market Share by Company in 2019

Figure 39. China Budesonide Sales Market Share by Type in 2019

Figure 40. China Budesonide Sales Market Share by Application in 2019

Figure 41. Japan Budesonide Sales Market Share by Company in 2019

Figure 42. Japan Budesonide Sales Market Share by Type in 2019

Figure 43. Japan Budesonide Sales Market Share by Application in 2019

Figure 44. Southeast Asia Budesonide Sales Market Share by Company in 2019

Figure 45. Southeast Asia Budesonide Sales Market Share by Type in 2019

Figure 46. Southeast Asia Budesonide Sales Market Share by Application in 2019

Figure 47. India Budesonide Sales Market Share by Company in 2019

Figure 48. India Budesonide Sales Market Share by Type in 2019

Figure 49. India Budesonide Sales Market Share by Application in 2019

Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Teva Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Mylan Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Cosmo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Salix Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Chiesi Farmaceutici Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. Orion Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Cipla Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. Synmosa Biopharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. Lunan Better Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 61. Shanghai Sine Promod Total Revenue (US$ Million): 2019 Compared with 2018

Figure 62. Key Raw Materials Price Trend

Figure 63. Manufacturing Cost Structure of Budesonide

Figure 64. Manufacturing Process Analysis of Budesonide

Figure 65. Budesonide Industrial Chain Analysis

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

Figure 68. Porter's Five Forces Analysis

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

---